Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

715 Press Releases
DateTitleCompany
22 May 12 New European guidelines set to benefit heart failure patients in the UK Pfizer
21 May 12 SMC recommends XIAPEX®q (Collagenase Clostridium Histolyticum) for NHS use Pfizer,
Published by
Red Consultancy
18 May 12 Pfizer Exploratory Study Measures Effects Of Lyrica (pregabalin) On Brain Activity In Fibromyalgia Patients Pfizer Inc.,
Published by
Business Wire
16 May 12 Pfizer Provides Topline Results From Phase 3 Study Of Torisel® As Second-Line Treatment In Advanced Renal Cell Carcinoma (RCC) Pfizer Inc,
Published by
Business Wire
14 May 12 Pfizer To Present New Data In Advanced Kidney, Lung And Hematologic Cancers At 2012 ASCO Annual Meeting Pfizer,
Published by
Business Wire
10 May 12 FDA Arthritis Advisory Committee Recommends Approval of Tofacitinib for Adult Patients with Moderately to Severely Active Rheumatoid Arthritis Pfizer Inc.,
Published by
Business Wire
09 May 12 New for pharmacists: online COPD resource at the click of a button Boehringer Ingelheim Ltd and Pfizer Ltd,
Published by
Porter Novelli
07 May 12 Pfizer Announces New Long-Term Relapse Prevention Data For PRISTIQ® (desvenlafaxine) 50 mg/day For The Treatment Of Major Depressive Disorder In Adults Pfizer Inc.,
Published by
Business Wire
04 May 12 Pfizer Reports Top-Line Results From Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Patients With Inadequately Treated Painful Diabetic Peripheral Neuropathy Pfizer Inc.,
Published by
Business Wire
04 May 12 Pfizer Stops Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Neuropathic Pain Associated With HIV Neuropathy Pfizer Inc.,
Published by
Business Wire
02 May 12 Pfizer And Protalix BioTherapeutics Announce FDA Approval Of ELELYSO™ (taliglucerase alfa) For The Treatment Of Gaucher Disease Pfizer Inc.,
Published by
Business Wire
01 May 12 Pfizer Reports First-Quarter 2012 Results Pfizer Inc.,
Published by
Business Wire
01 May 12 Pfizer Inc. Issues Statement Regarding Pending Court Case Pfizer Inc.,
Published by
Business Wire
25 Apr 12 The Advil® Congestion Relief Project Visits St. Louis To Expand Building Space For More Access To Local Family Social Service Program Pfizer Inc.,
Published by
Business Wire
23 Apr 12 Pfizer To Divest Nutrition Business To Nestlé Pfizer Inc.,
Published by
Business Wire
18 Apr 12 The Advil® Congestion Relief Project Visits Dayton To Relieve Community Center Congestion Allowing More Students To Participate In Local Mentorship Program Pfizer Inc.,
Published by
Business Wire
13 Apr 12 ADDING MULTIMEDIA The Advil® Congestion Relief Project Relieves Transportation Congestion in Albany to Help Get Students to Afterschool Programs Pfizer,
Published by
Business Wire
11 Apr 12 The Advil® Congestion Relief Project Relieves Transportation Congestion in Albany to Help Get Students to Afterschool Programs Pfizer,
Published by
Business Wire
26 Mar 12 Pfizer to Present New Data Highlighting Ongoing Research at 2012 Meeting of the American Association for Cancer Research Pfizer Oncology,
Published by
Business Wire
27 Mar 12 Pfizer Invites Public To View And Listen To Webcast Of May 1 Conference Call With Analysts Pfizer Inc.,
Published by
Business Wire
19 Mar 12 Pfizer Pledges to Strengthen Lifelong Health Strategies for Asia-Pacific Region During First World Congress on Healthy Ageing Pfizer Inc.,
Published by
Business Wire
15 Mar 12 Pfizer Acquires Alacer Corp., a Leading Vitamin Supplements Company Pfizer Inc.,
Published by
Business Wire
15 Mar 12 Pfizer’s Prevnar 13® Shown to be Immunogenic in Older Children and Adolescents Pfizer Inc.,
Published by
Business Wire
23 Feb 12 Pfizer Statement Regarding CDC’s ACIP Discussion of Prevnar 13® for Use in Adults Pfizer Inc.,
Published by
Business Wire
13 Mar 12 Biocon And Pfizer Conclude Commercialization Agreement Pfizer
15 Feb 12 FDA Accepts Pfizer’s New Drug Application for Tafamidis Meglumine, a Novel, Investigational Treatment for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP) Pfizer Inc.,
Published by
Business Wire
18 Feb 12 Pfizer And Hisun Announce Progress On Potential Joint Venture To Increase Access To High Quality Branded Generic Medicines Pfizer Inc.,
Published by
Business Wire
04 Apr 12 Inspra®?(eplerenone) now Approved for Reduction of Risk for Cardiovascular Morbidity and Mortality in Adult Patients with Chronic Heart Failure (NYHA Class II) and LVEF <30% Pfizer,
Published by
Ketchum Pleon Limited
09 Apr 12 “MasterChef” Judge Joe Bastianich Cooks With “Heart” At New Chicago Walgreens Flagship Store Pfizer Inc.,
Published by
Business Wire
04 Apr 12 Inspra®(eplerenone) now Approved for Reduction of Risk for Cardiovascular Morbidity and Mortality in Adult Patients with Chronic Heart Failure (NYHA Class II) and LVEF <30% Pfizer,
Published by
Ketchum Pleon Limited
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.